There is now ample evidence that ursodeoxycholic acid is the drug of choice
for the treatment of cholestatic liver diseases. It is probable that ursod
eoxycholic acid has to be administered for prolonged periods to see appreci
able reversal in liver damage. Nevertheless, disabling symptoms like ruritu
s are often brought under control and quality of Life improves. It is possi
ble that a combination therapy with a strong antiinflammatory drug to halt
immune destruction of liver cells will, be more beneficial than ursodeoxych
olic acid alone.